These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 17334514)

  • 1. Factor XIII Val34Leu variant protects against coronary artery disease. A meta-analysis.
    Vokó Z; Bereczky Z; Katona E; Adány R; Muszbek L
    Thromb Haemost; 2007 Mar; 97(3):458-63. PubMed ID: 17334514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor XIII Val34Leu variant is protective against venous thromboembolism: a HuGE review and meta-analysis.
    Wells PS; Anderson JL; Scarvelis DK; Doucette SP; Gagnon F
    Am J Epidemiol; 2006 Jul; 164(2):101-9. PubMed ID: 16740590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor XIII Val34Leu variant and the risk of myocardial infarction: a meta-analysis.
    Shafey M; Anderson JL; Scarvelis D; Doucette SP; Gagnon F; Wells PS
    Thromb Haemost; 2007 Apr; 97(4):635-41. PubMed ID: 17393027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor XIII val34leu and the risk of myocardial infarction.
    Franco RF; Pazin-Filho A; Tavella MH; Simões MV; Marin-Neto JA; Zago MA
    Haematologica; 2000 Jan; 85(1):67-71. PubMed ID: 10629595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor XIII Val34Leu polymorphism and the risk of myocardial infarction under the age of 36 years.
    Rallidis LS; Politou M; Komporozos C; Panagiotakos DB; Belessi CI; Travlou A; Lekakis J; Kremastinos DT
    Thromb Haemost; 2008 Jun; 99(6):1085-9. PubMed ID: 18521512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of the risk of coronary sclerosis/myocardial infarction by the interaction between factor XIII subunit A Val34Leu polymorphism and fibrinogen concentration in the high risk Hungarian population.
    Bereczky Z; Balogh E; Katona E; Pocsai Z; Czuriga I; Széles G; Kárpáti L; Adány R; Edes I; Muszbek L
    Thromb Res; 2007; 120(4):567-73. PubMed ID: 17250879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A common mutation in the gene for coagulation factor XIII-A (VAL34Leu): a risk factor for primary intracerebral hemorrhage is protective against atherothrombotic diseases.
    Gemmati D; Serino ML; Ongaro A; Tognazzo S; Moratelli S; Resca R; Moretti M; Scapoli GL
    Am J Hematol; 2001 Jul; 67(3):183-8. PubMed ID: 11391716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor XIII-A subunit Val34Leu polymorphism is associated with the risk of thrombosis in patients with antiphospholipid antibodies and high fibrinogen levels.
    de la Red G; Tàssies D; Espinosa G; Monteagudo J; Bové A; Plaza J; Cervera R; Reverter JC
    Thromb Haemost; 2009 Feb; 101(2):312-6. PubMed ID: 19190815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of p22phox gene C242T polymorphism with coronary artery disease: a meta-analysis.
    Fang S; Wang L; Jia C
    Thromb Res; 2010 May; 125(5):e197-201. PubMed ID: 20100625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-converting enzyme insertion/deletion gene polymorphic variant as a marker of coronary artery disease: a meta-analysis.
    Zintzaras E; Raman G; Kitsios G; Lau J
    Arch Intern Med; 2008 May; 168(10):1077-89. PubMed ID: 18504336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased factor XIII levels in factor XIII A subunit Leu34 homozygous patients with coronary artery disease.
    Bereczky Z; Balogh E; Katona E; Czuriga I; Kárpáti L; Shemirani AH; Edes I; Muszbek L
    Thromb Res; 2008; 121(4):469-76. PubMed ID: 17597187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor XIII-circulating levels and the Val34Leu polymorphism in the healthy male relatives of patients with severe coronary artery disease.
    Mills JD; Mansfield MW; Grant PJ
    Thromb Haemost; 2002 Mar; 87(3):409-14. PubMed ID: 11916071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of factor XIII Val34Leu polymorphism and coronary artery disease: A meta-analysis.
    Jung JH; Song GG; Kim JH; Seo YH; Choi SJ
    Cardiol J; 2017; 24(1):74-84. PubMed ID: 27665853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor XIII Val34Leu polymorphism as a modulator of fibrin clot permeability and resistance to lysis in patients with severe coronary artery disease.
    Stepień E; Plicner D; Kapelak B; Wypasek E; Sadowski J; Undas A
    Kardiol Pol; 2009 Aug; 67(8A):947-55. PubMed ID: 19784898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The homozygous leu variant of the factor XIII Val34Leu polymorphism as a risk factor for the manifestation of thrombotic microangiopathies.
    Sucker C; Farokhzad F; Kurschat C; Grabensee B; Scharf RE; Zotz RB; Maruhn-Debowski B; Hetzel GR
    Clin Appl Thromb Hemost; 2009; 15(2):197-200. PubMed ID: 17895511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of association between the platelet glycoprotein Ia C807T gene polymorphism and coronary artery disease: a meta-analysis.
    Tsantes AE; Nikolopoulos GK; Bagos PG; Vaiopoulos G; Travlou A
    Int J Cardiol; 2007 May; 118(2):189-96. PubMed ID: 17023078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pharmacogenetic effect of factor XIII valine 34 leucine polymorphism on fibrinolytic therapy for acute myocardial infarction.
    Marín F; González-Conejero R; Lee KW; Corral J; Roldán V; López F; Sogorb F; Caturla J; Lip GY; Vicente V
    J Am Coll Cardiol; 2005 Jan; 45(1):25-9. PubMed ID: 15629368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensinogen gene M235T polymorphism and risk of coronary artery disease: a meta-analysis.
    Wang YJ; Pan Y
    Mol Med Rep; 2012 Oct; 6(4):884-8. PubMed ID: 22842872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory cytokine gene variants in coronary artery disease patients in Greece.
    Manginas A; Tsiavou A; Chaidaroglou A; Giamouzis G; Degiannis D; Panagiotakos D; Cokkinos DV
    Coron Artery Dis; 2008 Dec; 19(8):575-82. PubMed ID: 19005292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor XIII Val34Leu is a genetic factor involved in the etiology of venous thrombosis.
    Franco RF; Reitsma PH; Lourenço D; Maffei FH; Morelli V; Tavella MH; Araújo AG; Piccinato CE; Zago MA
    Thromb Haemost; 1999 May; 81(5):676-9. PubMed ID: 10365735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.